Inventor · disambiguated record
Scott Harried
Also filed as: HARRIED SCOTT · HARRIED SCOTT S
30 granted patents·5 pending applications·117 citations·filing 2004–2025
96Inventor score
Top patents by PatentIndex Score
35 records- 0196US11724990B2Kv7 channel activators compositions and methods of useKNOPP BIOSCIENCES LLC·Filed 2022·Granted Aug 15, 2023·4 cites·14 claims
- 0296US11261162B2KV7 channel activators compositions and methods of useKNOPP BIOSCIENCES LLC·Filed 2020·Granted Mar 1, 2022·3 cites·20 claims
- 0395US10851067B2Kv7 channel activators compositions and methods of useKNOPP BIOSCIENCES LLC·Filed 2019·Granted Dec 1, 2020·6 cites·28 claims
- 0495US9481653B2Benzoimidazol-1,2-yl amides as Kv7 channel activatorsKNOPP BIOSCIENCES LLC·Filed 2015·Granted Nov 1, 2016·15 cites·19 claims
- 0593US9914708B2Benzoimidazol-1,2-yl amides as Kv7 channel activatorsKNOPP BIOSCIENCES LLC·Filed 2016·Granted Mar 13, 2018·10 cites·16 claims
- 0692US10385025B2Benzoimidazol-1,2-yl amides as Kv7 channel activatorsKNOPP BIOSCIENCES LLC·Filed 2018·Granted Aug 20, 2019·9 cites·16 claims
- 0791US9650376B2Imidazo(4,5-B) pyridin-2-yl amides as KV7 channel activatorsKNOPP BIOSCIENCES LLC·Filed 2014·Granted May 16, 2017·8 cites·23 claims
- 0889US7538114B2Glycine transporter-1 inhibitorsAMGEN INC·Filed 2007·Granted May 26, 2009·14 cites·43 claims
- 0988US12351559B2Benzoimidazol benzomidazol-1,2-yl amides as Kv7 channel activatorsBIOHAVEN THERAPEUTICS LTD·Filed 2023·Granted Jul 8, 2025·0 cites·16 claims
- 1086US7872009B2Beta-Secretase modulators and methods of useAMGEN INC·Filed 2006·Granted Jan 18, 2011·11 cites·8 claims
- 1184US10906877B2Benzoimidazol-1,2-yl amides as Kv7 channel activatorsKNOPP BIOSCIENCES LLC·Filed 2019·Granted Feb 2, 2021·1 cites·8 claims
- 1284US9296698B2Amino heteroaryl compounds as beta-secretase modulators and methods of useCHENG YUAN·Filed 2010·Granted Mar 29, 2016·5 cites·14 claims
- 1383US12286408B2KV7 channel activators compositions and methods of useBIOHAVEN THERAPEUTICS LTD·Filed 2023·Granted Apr 29, 2025·0 cites·16 claims
- 1482US9096527B2TRPM8 antagonists and their use in treatmentsAMGEN INC·Filed 2014·Granted Aug 4, 2015·5 cites·38 claims
- 1580US7320992B2Substituted 2,3-dihydro-1h-isoindol-1-one derivatives and methods of useAMGEN INC·Filed 2004·Granted Jan 22, 2008·15 cites·38 claims
- 1677US7745484B2Beta-secretase modulators and methods of useAMGEN INC·Filed 2006·Granted Jun 29, 2010·2 cites·15 claims
- 1775US11834418B2Benzoimidazol-1,2-yl amides as Kv7 channel activatorsBIOHAVEN THERAPEUTICS LTD·Filed 2020·Granted Dec 5, 2023·0 cites·20 claims
- 1872US7973047B2Beta-Secretase modulators and methods of useAMGEN INC·Filed 2010·Granted Jul 5, 2011·2 cites·21 claims
- 1970US8778941B2TRPM8 antagonists and their use in treatmentsBROWN JAMES·Filed 2012·Granted Jul 15, 2014·1 cites·33 claims
- 2070US7838676B2Beta-secretase modulators and methods of useAMGEN INC·Filed 2006·Granted Nov 23, 2010·1 cites·11 claims
- 2168US10526328B2Imidazo[4,5-b]pyridin-2-yl amides as Kv7 channel activatorsKNOPP BIOSCIENCES LLC·Filed 2018·Granted Jan 7, 2020·0 cites·1 claims
- 2267US7393852B2Piperazine derivatives and methods of useAMGEN INC·Filed 2004·Granted Jul 1, 2008·3 cites·42 claims
- 2365US8183244B2Glycine transporter-1 inhibitorsHITCHCOCK STEPHEN·Filed 2009·Granted May 22, 2012·0 cites·35 claims
- 2465US7425631B2Compounds and methods of useAMGEN INC·Filed 2004·Granted Sep 16, 2008·2 cites·6 claims
- 2562US9663476B2Glycine transporter-1 inhibitorsAMGEN INC·Filed 2014·Granted May 30, 2017·0 cites·20 claims
- 2661US2025368668A1Crystalline forms and salt forms of a cardiac p2x receptor agonist, pharmaceutical compositions, and their use in treating medical disordersCORNOVUS PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 2760US8163909B2Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of useZHONG WENGE·Filed 2008·Granted Apr 24, 2012·0 cites·17 claims
- 2857US2009048224A1Compounds and methods of useAMGEN INC·Filed 2008·Application pending·0 cites
- 2954US2009054460A1Piperazine derivatives and methods of useCHEN JIAN J·Filed 2008·Application pending·0 cites
- 3052US2014235642A1Trpm8 antagonists and their use in treatmentsAMGEN INC·Filed 2014·Application pending·0 cites
- 3148US2015031668A1Chroman derivatives as trpm8 inhibitorsAMGEN INC·Filed 2014·Application pending·0 cites
- 3246US8952009B2Chroman derivatives as TRPM8 inhibitorsAMGEN INC·Filed 2013·Granted Feb 10, 2015·0 cites·57 claims
- 3346US8735383B2Glycine transporter-1 inhibitorsSTEPHEN HITCHCOCK·Filed 2012·Granted May 27, 2014·0 cites·25 claims
- 3446US8552181B2Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of useZHONG WENGE·Filed 2012·Granted Oct 8, 2013·0 cites·12 claims
- 3543US8163766B2Beta-secretase modulators and methods of useZHONG WENGE·Filed 2010·Granted Apr 24, 2012·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Scott Harried files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →